Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cliniphar Co., Ltd. (432A:JPX), powered by AI.
Cliniphar Co., Ltd. is currently trading at ¥1,450. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cliniphar Co., Ltd. on Alpha Lenz.
View Cliniphar Co., Ltd.'s valuation metrics on Alpha Lenz.
“Cliniphar Co., Ltd.'s ROE is 20.2%. Explore profitability and growth together.”
Ask for details →Cliniphar Co., Ltd. is a holding company specializing in the wholesale and distribution of pharmaceuticals within both domestic Japanese and international markets. Established in 2017, it plays a pivotal role in advancing healthcare logistics by integrating subsidiaries and leveraging synergies across the healthcare industry, with a focus on delivering efficiency and innovation to pharmaceutical distribution. Cliniphar manages a substantial portfolio, distributing more than 17,000 prescription products and collaborating with approximately 12,000 healthcare professionals and institutions. The company operates B2B e-commerce platforms designed for healthcare providers, such as Kosei Market, and maintains digital drug databases such as Synapse, supporting both the Japanese and global medical sectors. Located in Osaka, Cliniphar aims to streamline drug supply chains, ensuring prompt and stable access to a broad range of pharmaceuticals for hospitals, clinics, and pharmacies. Its market presence underscores its significance as a facilitator of supply chain innovation and reliability, serving as an essential intermediary in the healthcare ecosystem.
“Cliniphar Co., Ltd.'s ROE is 20.2%. Explore profitability and growth together.”
Ask for details →Cliniphar Co., Ltd. (ticker: 432A) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers).
The current price is 1,450 with a P/E ratio of -x and P/B of -x.
ROE is 20.19% and operating margin is 4.12%. Annual revenue is $3.6B.